Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
Humana Military Earns URAC Accreditations in Case and Disease Management
Humana Military Earns URAC Accreditations in Case and Disease Management


Humana Military, a wholly owned subsidiary of Humana Inc. (NYSE: HUM), announced today that it has earned a three-year Case Management Accreditation and a Disease Management Accreditation from URAC

AMN Named Among Top Corporate Boards in Diversity, Equity, and Inclusion Awards
AMN Named Among Top Corporate Boards in Diversity, Equity, and Inclusion Awards


The AMN Healthcare Board of Directors is one of 10 boards nationwide named as best of the best and finalists for the 2021 National Association of Corporate Directors (NACD) Diversity, Equity &amp

LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting
LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting taking place December

Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has extended its

Chemed Corporation to Present at the BofA Securities 2021 Virtual Home Care Conference
Chemed Corporation to Present at the BofA Securities 2021 Virtual Home Care Conference


Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2021 Virtual Home Care Conference on Tuesday, December 7, 2021, at 11:00 AM (ET).



The presentation will

Orlando Health Forms Joint Venture With Acadia Healthcare to Expand Behavioral Health Services in the Region
Orlando Health Forms Joint Venture With Acadia Healthcare to Expand Behavioral Health Services in the Region


Orlando Health and Acadia Healthcare Company announced today that they have formed a joint venture designed to enhance and expand behavioral health services in the region.


This press release

Acadia Healthcare Forms Joint Venture With Orlando Health
Acadia Healthcare Forms Joint Venture With Orlando Health


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Orlando Health, one of Central Florida’s premier health systems. With Acadia’s partnership

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference
LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place

PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth


Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)

DGAP-News: Fresenius Medical Care AG & Co. KGaA announces changes to Management Board, reflecting the transformation to the company's new operating model
DGAP-News: Fresenius Medical Care AG & Co. KGaA announces changes to Management Board, reflecting the transformation to the company's new operating model
DGAP-News: Fresenius Medical Care AG & Co. KGaA announces changes to Management Board, reflecting the transformation to the company's new operating model
DGAP-News: Fresenius Medical Care AG & Co. KGaA passt Besetzung des Vorstands an neues Betriebsmodell an
DGAP-News: Fresenius Medical Care AG & Co. KGaA passt Besetzung des Vorstands an neues Betriebsmodell an
DGAP-News: Fresenius Medical Care AG & Co. KGaA passt Besetzung des Vorstands an neues Betriebsmodell an
Quidel Statement on the Omicron Variant
Quidel Statement on the Omicron Variant


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement from

Loudoun Medical Group Joins Humana Medicare Advantage Network
Loudoun Medical Group Joins Humana Medicare Advantage Network


Loudoun Medical Group, P.C. (LMG), one of the largest and most diverse physician-owned, multi-specialty group practices in Virginia, and leading health and well-being company Humana Inc. (NYSE

AMN Healthcare CEO Susan Salka Named to Global Power 150 – Women in Staffing for Seventh Consecutive Year
AMN Healthcare CEO Susan Salka Named to Global Power 150 – Women in Staffing for Seventh Consecutive Year


Susan Salka, President and CEO of AMN Healthcare (NYSE: AMN), has been named to the 2021 Global Power 150 – Women in Staffing by Staffing Industry Analysts for the seventh consecutive year.



The

Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope


Simulations Plus, Inc. (Nasdaq: SLP) is celebrating 25 years in business and continuing the commitment to improve public health through innovative solutions with a $25,000 donation to the

Owens & Minor to Present at Bank of America Leveraged Finance Conference
Owens & Minor to Present at Bank of America Leveraged Finance Conference


Owens & Minor, Inc. (NYSE-OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, today announced that Andy

DGAP-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
DGAP-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
DGAP-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
DGAP-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014 in Verbindung mit Art. 2 Abs. 2 und Abs. 3 der Delegierten Verordnung (EU) 2016/1052
DGAP-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014 in Verbindung mit Art. 2 Abs. 2 und Abs. 3 der Delegierten Verordnung (EU) 2016/1052
DGAP-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014 in Verbindung mit Art. 2 Abs. 2 und Abs. 3 der Delegierten Verordnung (EU) 2016/1052
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Net sales and earnings decline in 2022
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Net sales and earnings decline in 2022
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Net sales and earnings decline in 2022
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Umsatz und Ergebnisrückgang in 2022
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Umsatz und Ergebnisrückgang in 2022
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Umsatz und Ergebnisrückgang in 2022
Gerresheimer AG: Gerresheimer begibt erfolgreich Schuldschein - Emission erneut deutlich überzeichnet
Gerresheimer AG: Gerresheimer begibt erfolgreich Schuldschein - Emission erneut deutlich überzeichnet
Gerresheimer AG: Gerresheimer begibt erfolgreich Schuldschein - Emission erneut deutlich überzeichnet
Gerresheimer AG: Gerresheimer successfully issues promissory loan - transaction again significantly oversubscribed
Gerresheimer AG: Gerresheimer successfully issues promissory loan - transaction again significantly oversubscribed
Gerresheimer AG: Gerresheimer successfully issues promissory loan - transaction again significantly oversubscribed
Sernova kündigt Vortrag des Hauptprüfers seiner klinischen Studie beim 21. Winter Symposium der American Society of Transplant Surgeons an
Sernova kündigt Vortrag des Hauptprüfers seiner klinischen Studie beim 21. Winter Symposium der American Society of Transplant Surgeons an

LONDON, ONTARIO – 30. November 2020 – Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF)(FWB:PSH) – ein führendes Unternehmen für Therapeutika der regenerativen Medizin, das klinische Studien durchführt

Sernova Announces Clinical Trial Investigator Presentation at the ASTS 21st Winter Symposium
Sernova Announces Clinical Trial Investigator Presentation at the ASTS 21st Winter Symposium

LONDON, ONTARIO – November 30, 2020Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF)(FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that Dr.